Status:
TERMINATED
Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to learn about the effects of cancer treatment on the brain. Some cancer patients report changes in their memory or thinking after treatment. These changes could be a resu...
Eligibility Criteria
Inclusion
- Patients between the ages of 18 and 80 years old
- As per self report and/or medical record female patients are either postmenopausal or not able to become pregnant
- Patients with biopsy proven or suspected non-small cell lung cancer planned to undergo induction chemotherapy and surgery, OR with biopsy proven or suspected non-small cell lung cancer planned to undergo immediate surgical resection
- No clinical/neurological symptoms suggestive of brain metastases by attending's judgment as documented in the medical record and/or correspondence with the research team
- In the judgement of the consenting professional, patient is able to understand English, through verbal and written communication
- Patient is able to undergo MRI scanning (verified with pre-MRI Safety Screening form (Appendix A) used in MSKCC MRI Centers) completed at screening and again prior to having the MRI.
Exclusion
- Patients with history of significant neurological diagnoses including stroke, tumor, dementia, epilepsy, or multiple sclerosis as indicated by medical records and/or self report
- History of head injury with evidence of brain injury or loss of consciousness for \> 60 minutes as per EMR or self-report
- No prior treatment with chemotherapy
- Participant has dentures, body jewelry or wig that they are unable to remove as per self-report
- Patient reports that he/she cannot undergo MRI scanning without significant distress or discomfort
- Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the study (i.e., schizophrenia).
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01473693
Start Date
November 1 2011
End Date
January 1 2014
Last Update
January 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065